Auna (AUNA) Stock Price, News & Analysis

Company Overview

Auna S.A., a healthcare service provider, operates hospitals and clinics in Mexico, Peru, and Colombia. The company provides prepaid healthcare plans in Peru; and dental and vision plans in Mexico. The company was founded in 1989 and is based in Luxembourg, Luxembourg.

Key Stats

• Today's Range: $6.29 to $6.47
• 50-Day Range: $6.31 to $7.21
• 52-Week Range: $6.13 to $9.38
• Volume: 115,345 shs
• Average Volume: 55,706 shs
• Market Capitalization: $471.44 million
• P/E Ratio: 10.98
• Dividend Yield: N/A
• Price Target: $10.70
• Consensus Rating: Hold

Auna Stock Analysis - MarketRank™

Auna scored higher than 71% of companies evaluated by MarketBeat, and ranked 587th out of 1,880 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 3.2 / 5
• Analyst Rating: Hold

Consensus Rating

Auna has received a consensus rating of Hold. The company's average rating score is 2.33, and is based on 1 buy rating, 2 hold ratings, and no sell ratings.

Amount of Analyst Coverage

Auna has only been the subject of 2 research reports in the past 90 days.

Earnings and Valuation

• Score: 3.1 / 5
• Proj. Earnings Growth: 58.00%

Earnings Growth

Earnings for Auna are expected to grow by 58.00% in the coming year, from $0.50 to $0.79 per share.

Price to Earnings Ratio vs. the Market

The P/E ratio of Auna is 10.98, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 23.41.

Price to Earnings Ratio vs. Sector

The P/E ratio of Auna is 10.98, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 25.94.

Price to Book Value per Share Ratio

Auna has a P/B Ratio of 1.09. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

Short Interest

• Score: 3.0 / 5
• Short Interest Level: Healthy

Percentage of Shares Shorted

0.63% of the float of Auna has been sold short.

Short Interest Ratio / Days to Cover

Auna has a short interest ratio ("days to cover") of 5.6.

Change versus previous month

Short interest in Auna has recently decreased by 4.37%, indicating that investor sentiment is improving.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

Auna does not currently pay a dividend.

Dividend Growth

Auna does not have a long track record of dividend growth.

Sustainability and ESG

• Score: N/A
• Environmental Score: N/A

Percentage of Shares Shorted

0.63% of the float of Auna has been sold short.

Short Interest Ratio / Days to Cover

Auna has a short interest ratio ("days to cover") of 5.6.

Change versus previous month

Short interest in Auna has recently decreased by 4.37%, indicating that investor sentiment is improving.

News and Social Media

• Score: 1.2 / 5
• News Sentiment: 0.07

News Sentiment

Auna has a news sentiment score of 0.07. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.90 average news sentiment score of Medical companies.

News Coverage This Week

MarketBeat has tracked 2 news articles for Auna this week, compared to 2 articles on an average week.

Search Interest

Only 4 people have searched for AUNA on MarketBeat in the last 30 days. This is a decrease of 0% compared to the previous 30 days.

Company Ownership

• Score: N/A
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, Auna insiders have not sold or bought any company stock.

AUNA Stock Analysis - Frequently Asked Questions

How have AUNA shares performed this year?

Auna's stock was trading at $6.86 on January 1st, 2025. Since then, AUNA stock has decreased by 7.1% and is now trading at $6.37.
View the best growth stocks for 2025 here.

How were Auna's earnings last quarter?

Auna S.A. (NYSE:AUNA) issued its quarterly earnings results on Tuesday, May, 20th. The company reported $0.19 EPS for the quarter, beating analysts' consensus estimates of $0.16 by $0.03. The company had revenue of $281.43 million for the quarter, compared to analyst estimates of $1.12 billion. Auna had a trailing twelve-month return on equity of 10.39% and a net margin of 3.67%.
Read the conference call transcript.

When did Auna IPO?

Auna (AUNA) raised $360 million in an initial public offering (IPO) on Friday, March 22nd 2024. The company issued 30,000,000 shares at $12.00 per share.

Who are Auna's major shareholders?

Auna's top institutional investors include Fiera Capital Corp (2.05%), Deltec Asset Management LLC (0.12%), Goldman Sachs Group Inc. (0.04%) and Russell Investments Group Ltd. (0.02%).

How do I buy shares of Auna?

Shares of AUNA stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of Auna own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Auna investors own include Nuvation Bio (NUVB), UiPath (PATH), Carnival (CCL), CRISPR Therapeutics (CRSP), Canoo (GOEV) and Taiwan Semiconductor Manufacturing (TSM).

Company Calendar

• Last Earnings: 5/20/2025
• Today: 6/17/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: NYSE
• Sector: Medical
• Industry: Medical Services
• Sub-Industry: Healthcare
• Current Symbol: NYSE:AUNA
• Previous Symbol: NYSE:AUNA
• CIK: 1799207
• Web: aunainvestors.com
• Phone: 512053500
• Fax: N/A
• Employees: 14,842
• Year Founded: N/A

Price Target and Rating

• Average Stock Price Target: $10.70
• High Stock Price Target: $13.50
• Low Stock Price Target: $7.90
• Potential Upside/Downside: +68.0%
• Consensus Rating: Hold
• Rating Score (0-4): 2.33
• Research Coverage: 3 Analysts

Profitability

• EPS (Most Recent Fiscal Year): $0.58
• Trailing P/E Ratio: 10.57
• Forward P/E Ratio: 12.74
• P/E Growth: N/A
• Net Income: $29.39 million
• Net Margins: 3.67%
• Pretax Margin: 5.29%
• Return on Equity: 10.39%
• Return on Assets: 2.38%

Debt

• Debt-to-Equity Ratio: 1.76
• Current Ratio: 0.83
• Quick Ratio: 0.78

Sales & Book Value

• Annual Sales: $1.17 billion
• Price / Sales: 0.40
• Cash Flow: $1.18 per share
• Price / Cash Flow: 5.40
• Book Value: $5.85 per share
• Price / Book: 1.09

Miscellaneous

• Outstanding Shares: 74,010,000
• Free Float: N/A
• Market Cap: $471.44 million
• Optionable: N/A
• Beta: 2.47